An international systematic review of smoking prevalence in addiction treatment

Addiction

Volumn 111, Issue 2, 2016, Pages 220-230

  Guydish, Joseph ^a   Passalacqua, Emma ^a   Pagano, Anna ^a   Martínez, Cristina ^b   Le, Thao ^a   Chun, Jongserl ^c   Tajima, Barbara ^a   Docto, Lindsay ^a   Garina, Daria ^a   Delucchi, Kevin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c Ewha Womans University   (South Korea)

Author keywords

Addiction; Co substance use; Global health; Priority special populations; Smoking; Surveillance and monitoring; Tobacco

Indexed keywords

FEMALE; GLOBAL HEALTH; HUMAN; MALE; PREVALENCE; PREVENTION AND CONTROL; SMOKING; SUBSTANCE-RELATED DISORDERS;

FEMALE; GLOBAL HEALTH; HUMANS; MALE; PREVALENCE; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84954293884     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13099     Document Type: Article

References (96)

1. World Health Organization (WHO). WHO Global Report: Mortality Attributable to Tobacco. Geneva: WHO; 2012.
2. World Health Organization (WHO). WHO report on the Global Tobacco Epidemic. Geneva: WHO; 2013.
3. Giovino G. A., Mirza S. A., Samet J. M., Gupta P. C., Jarvis M. J., Bhala N. et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380: 668-79.
4. Joossens L., Raw M. The Tobacco Control Scale: a new scale to measure country activity. Tob Control 2006; 15: 247-53.
5. Martínez C., Martínez-Sánchez J. M., Robinson G., Bethke C., Fernández E. Protection from secondhand smoke in countries belonging to the WHO European Region: an assessment of legislation. Tob Control 2014; 23: 403-11.
6. Ferketich A. K., Lugo A., La Vecchia C., Fernandez E., Boffetta P., Clancy L. et al. Relation between national-level tobacco control policies and individual-level voluntary home smoking bans in Europe. Tob Control 2014; doi: 10.1136/tobaccocontrol-2014-051819.
7. Martinez-Sanchez J. M., Blanch C., Fu M., Gallus S., La Vecchia C., Fernandez E. Do smoke-free policies in work and public places increase smoking in private venues? Tob Control 2014; 23: 204-7.
8. Szatkowski L., McNeill A. The delivery of smoking cessation interventions to primary care patients with mental health problems. Addiction 2013; 8: 1487-1494.
9. Kalman D., Morissette S. B., George T. P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14: 106-23.
10. Compton W. M., Thomas Y. F., Stinson F. S., Grant B. F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the united states: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007; 64: 566-76.
11. Substance Abuse and Mental Health Services Administration Results from the 2008 National Survey on Drug Use and Health: National Findings. In: NSDUH Series H-36, HHS Publication no. SMA 09-4434. Rockville, MD: Office of Applied Studies; 2009.
12. Hser Y. I., McCarthy W. J., Anglin M. D. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med 1994; 23: 61-9.
13. Hurt R. D., Offord K. P., Croghan I. T., Gomez-Dahl L., Kottke T. E., Morse R. M. et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996; 275: 1097-103.
14. Tsoh J. Y., Chi F. W., Mertens J. R., Weisner C. M. Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. Drug Alcohol Depend 2011; 114: 110-8.
15. Guydish J., Passalacqua E., Tajima B., Chan M., Chun J., Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res 2011; 13: 401-11.
16. Guydish J., Yu J., Le T., Pagano A., Delucchi K. Predictors of tobacco use among New York State addiction treatment patients. Am J Public Health 2015; 105: e57-64.
17. Moher D., Liberati A., Tetzlaff J., Altman D. G., the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med 2009; 6e1000097: .
18. Teichtahl H., Prodromidis A., Miller B., Cherry G., Kronborg I. Sleep-disordered breathing in stable methadone programme patients: a pilot study. Addiction 2001; 96: 395-403.
19. Gossop M., Neto D., Radovanovic M., Batra A., Toteva S., Musalek M. et al. Physical health problems among patients seeking treatment for alcohol use disorders: a study in six European cities. Addict Biol 2007; 12: 190-6.
20. Basu D., Banerjee A., Harish T., Mattoo S. K. Disproportionately high rate of epileptic seizure in patients abusing dextropropoxyphene. Am J Addict 2009; 18: 417-21.
21. Shakeshaft A. P., Bowman J. A., Sanson-Fisher R. W. Computers in community-based drug and alcohol clinical settings: are they acceptable to respondents? Drug Alcohol Depend 1998; 50: 177-80.
22. Thavarajah R., Rao A., Raman U., Rajasekaran S. T., Joshua E., Hemalatha R. et al. Oral lesions of 500 habitual psychoactive substance users in Chennai, India. Arch Oral Biol 2006; 51: 512-9.
23. Zullino D. F., Besson J., Favrat B., Krenz S., Zimmermann G., Schnyder C. et al. Acceptance of an intended smoking ban in an alcohol dependence clinic. Eur Psychiatry 2003; 18: 255-7.
24. Aubin H., Tilikete S., Laureaux C., Nguyen Hac H., Roullet-Volmi M., Troupel S. et al. Smoking and coffee intake following alcohol withdrawal in alcoholic inpatients. Eur Psychiatry 1995; 10: 383-5.
25. Darke S., Swift W., Hall W., Ross M. Predictors of injecting and injecting risk-taking behaviour among methadone maintenance clients. Addiction 1994; 89: 311-6.
26. Lahmek P., Berlin I., Michel L., Berghout C., Meunier N., Aubin H. J. Determinants of improvement in quality of life of alcohol-dependent patients during an inpatient withdrawal programme. Int J Med Sci 2009; 6: 160-7.
27. Liao Y., Tang J., Liu T., Chen X., Luo T., Hao W. Sleeping problems among Chinese heroin-dependent individuals. Am J Drug Alcohol Abuse 2011; 37: 179-83.
28. Malik P., Gasser R. W., Kemmler G., Moncayo R., Finkenstedt G., Kurz M. et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 2009; 33: 375-81.
29. Ohlmeier M. D., Peters K., Kordon A., Seifert J., Wildt B. T., Wiese B. et al. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol 2007; 42: 539-43.
30. Palmer F., Jaffray M., Moffat M. A., Matheson C., McLernon D. J., Coutts A. et al. Prevalence of common chronic respiratory diseases in drug misusers: a cohort study. Prim Care Respir J 2012; 21: 377-83.
31. Perneger T. V., Giner F., del Rio M., Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998; 317: 13-8.
32. Teichtahl H., Wang D., Cunnington D., Kronborg I., Goodman C., Prodromidis A. et al. Cardiorespiratory function in stable methadone maintenance treatment (MMT) patients. Addict Biol 2004; 9: 247-53.
33. Walter M., Wiesbeck G. A., Degen B., Albrich J., Oppel M., Schulz A. et al. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol 2010; 16: 145-51.
34. Zullino D., Besson J., Schnyder C. Stage of change of cigarette smoking in alcohol-dependent patients. Eur Addict Res 2000; 6: 84-90.
35. Ellingstad T. P., Sobell L. C., Sobell M. B., Cleland P. A., Agrawal S. Alcohol abusers who want to quit smoking: implications for clinical treatment. Drug Alcohol Depend 1999; 54: 259-65.
36. Ercan E. S., Coskunol H., Varan A., Toksoz K. Childhood attention deficit/hyperactivity disorder and alcohol dependence: a 1-year follow-up. Alcohol Alcohol 2003; 38: 352-6.
37. Schmidt L. G., Smolka M. Relapse prevention in alcoholics by cigarette smoking? Involvement of nicotinic-dopaminergic mechanisms. Alcohol 2001; 24: 111-5.
38. Toneatto A., Sobell L. C., Sobell M. B., Kozlowski L. T. Effect of cigarette smoking on alcohol treatment outcome. J Subst Abuse 1995; 7: 245-52.
39. Basu D., Aggarwal M., Das P. P., Mattoo S. K., Kulhara P., Varma V. K. Changing pattern of substance abuse in patients attending a de-addiction centre in north India (1978-2008). Ind J Med Res 2012; 135: 830-6.
40. Dunn J., Laranjeira R. Cocaine-profiles, drug histories, and patterns of use of patients from Brazil. Subst Use Misuse 1999; 34: 1527-48.
41. Diehl A., Silva R. L., Laranjeira R. Female sexual dysfunction in patients with substance-related disorders. Clinics 2013; 68: 205-12.
42. de Los P., Cobos J., Sinol N., Puerta C., Cantillano V., Lopez Zurita C. et al. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders. Psychiatry Res 2011; 185: 205-10.
43. Guydish J., Passalacqua E., Tajima B., Chan M., Chun J., Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res 2011; 13: 401-11.
44. Pajusco B., Boschini A., Chiamulera C., Benigni M., Smacchia C., Lugoboni F. Tobacco smoking prevalence in a large sample of heroin users accessing rehabilitation. Heroin Addict Relat Clin Probl 2011; 3: 5-10.
45. Kozlowski L. T., Skinner W., Kent C., Pope M. A. Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. Addict Behav 1989; 14: 273-8.
46. de los Boto B. A., Pereira Vega A., Sanchez Ramos J. L., Maldonado Perez J. A., Ayerbe Garcia R., Garcia Jimenez D. et al. Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. Chest 2002; 121: 1223-30.
47. Pastorelli R., Bardazzi G., Saieva C., Cerri A., Gestri D., Allamani A. et al. Genetic determinants of alcohol addiction and metabolism: a survey in Italy. Alcohol Clin Exp Res 2001; 25: 221-7.
48. Kampov-Polevoy A. B., Tsoi M. V., Zvartau E. E., Neznanov N. G., Khalitov E. Sweet liking and family history of alcoholism in hospitalized alcoholic and non-alcoholic patients. Alcohol Alcohol 2001; 36: 165-70.
49. Elkader A. K., Brands B., Selby P., Sproule B. A. Methadone-nicotine interactions in methadone maintenance treatment patients. J Clin Psychopharmacol 2009; 29: 231-8.
50. Richter K. P., Hamilton A. K., Hall S., Catley D., Cox L. S., Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Exp Clin Psychopharmacol 2007; 15: 144-53.
51. Vandenbergh D. J., O'Connor R. J., Grant M. D., Jefferson A. L., Vogler G. P., Strasser A. A. et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol 2007; 12: 106-16.
52. Hughes J. Do smokers with current or past alcoholism need different or more intensive treatment? Alcohol Clin Exp Res 2002; 26: 1934-5.
53. Sobell L. C., Sobell M. B., Agrawal S. Self-change and dual recoveries among individuals with alcohol and tobacco problems: current knowledge and future directions. Alcohol Clin Exp Res 2002; 26: 1936-8.
54. Drobes D. J. Cue reactivity in alcohol and tobacco dependence. Alcohol Clin Exp Res 2002; 26: 1928-9.
55. Prochaska J. J., Delucchi K., Hall S. M. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004; 72: 1144-56.
56. Guydish J., Passalacqua E., Tajima B., Manser S. T. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J Psychoact Drugs 2007; 39: 423-33.
57. Richter K. P., Choi W. S., McCool R. M., Harris K. J., Ahluwalia J. S. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatr Serv 2004; 55: 1258-64.
58. Fuller B. E., Guydish J., Tsoh J., Reid M. S., Resnick M., Zammarelli L. et al. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat 2007; 32: 53-60.
59. Friedmann P. D., Jiang L., Richter K. P. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat 2008; 34: 165-72.
60. Bobo J. K., Gilchrist L. D. Urging the alcoholic client to quit smoking cigarettes. Addict Behav 1983; 8: 297-305.
61. Gill B. S., Bennett D. L. Addiction professionals' attitudes regarding treatment of nicotine dependence. J Subst Abuse Treat 2000; 19: 317-8.
62. Prochaska J. J., Fletcher L., Hall S. E., Hall S. M. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict 2006; 15: 15-22.
63. Prochaska J. J., Reyes R. S., Schroeder S. A., Daniels A. S., Doederlein A., Bergeson B. An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disord 2011; 13: 466-73.
64. World Health Organization (WHO) Systematic Review of the Link Between Tobacco and Poverty. Geneva: WHO; 2011.
65. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health 2014. Available at: https://nsduhweb.rti.org/respweb/homepage.cfm (accessed 7November 2014).
66. Burns L., Mattick R. P., Lim K., Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-70.
67. Shakeshaft A. P., Bowman J. A., Sanson-Fisher R. W. Community-based drug and alcohol counselling: who attends and why? Drug Alcohol Rev 2002; 21: 153-62.
68. Zador D., Lyons Wall P. M., Webster I. High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction 1996; 91: 1053-61.
69. Hoflich A. S., Langer M., Jagsch R., Bawert A., Winklbaur B., Fischer G. et al. Peripartum pain management in opioid dependent women. Eur J Pain 2012; 16: 574-84.
70. Winklbaur B., Baewert A., Jagsch R., Rohrmeister K., Metz V., Aeschbach Jachmann C. et al. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res 2009; 15: 150-6.
71. Baltieri D. A., Daro F. R., Ribeiro P. L., Andrade A. G. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. Drug Alcohol Depend 2009; 105: 33-41.
72. de Meneses-Gaya C., Zuardi A. W., de Azevedo Marques J. M., Souza R. M., Loureiro S. R., Crippa J. A. Psychometric qualities of the Brazilian versions of the Fagerstrom Test for Nicotine Dependence and the Heaviness of Smoking Index. Nicotine Tob Res 2009; 11: 1160-5.
73. Nenadic-Sviglin K., Nedic G., Nikolac M., Kozaric-Kovacic D., Stipcevic T., Muck Seler D. et al. Suicide attempt, smoking, comorbid depression, and platelet serotonin in alcohol dependence. Alcohol 2011; 45: 209-16.
74. Aubin H. J., Laureaux C., Tilikete S., Barrucand D. Changes in cigarette smoking and coffee drinking after alcohol detoxification in alcoholics. Addiction 1999; 94: 411-6.
75. Batel P., Pessione F., Maitre C., Rueff B. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction 1995; 90: 977-80.
76. Levy P., Mathurin P., Roqueplo A., Rueff B., Bernades P. A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas 1995; 10: 231-8.
77. Donath C., Metz K., Chmitorz A., Gradl S., Piontek D., Floter S. et al. Prediction of alcohol addicted patients' smoking status through hospital tobacco control policy: a multi-level-analysis. Drugs Educ Prev Policy 2009; 16: 53-70.
78. Hillemacher T., Weinland C., Heberlein A., Wilhelm J., Bayerlein K., Kornhuber J. et al. Treatment with clomethiazole is associated with lower rates of premature discharge during alcohol withdrawal. Pharmacopsychiatry 2008; 41: 134-7.
79. Hintz T., Mann K. Long-term behavior in treated alcoholism: Evidence for beneficial carry-over effects of abstinence from smoking on alcohol use and vice versa. Addict Behav 2007; 32: 3093-100.
80. Huttner E., Matthies U., Nikolova T., Ehrenreich H. A follow-up study on chromosomal aberrations in lymphocytes of alcoholics during early, medium, and long-term abstinence. Alcohol Clin Exp Res 1999; 23: 344-8.
81. Mattoo S. K., Chakraborty K., Basu D., Ghosh A., Vijaya Kumar K. G., Kulhara P. Prevalence and correlates of metabolic syndrome in alcohol and opioid dependent inpatients. Ind J Med Res 2011; 134: 341-8.
82. Rooban T., Rao A., Joshua E., Ranganathan K. The prevalence of oral mucosal lesions in alcohol misusers in Chennai, south India. Ind J Dent Res 2009; 20: 41-6.
83. Amit Z., Weiss S., Smith B. R., Markevitch S. The affinity for sweet substances and cigarette smoking in chronic alcoholism. Isr J Psychiatry Relat Sci 2003; 40: 96-102.
84. Pajusco B., Chiamulera C., Quaglio G., Moro L., Casari R., Amen G. et al. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. Int J Environ Res Public Health 2012; 9: 932-42.
85. Barbadoro P., Ponzio E., Pertosa M. E., Aliotta F., D'Errico M. M., Prospero E. et al. The effects of educational intervention on nutritional behaviour in alcohol-dependent patients. Alcohol Alcohol 2011; 46: 77-9.
86. Barbadoro P., Lucrezi D., Prospero E., Annino I. Improvement of knowledge, attitude, and behavior about oral health in a population of alcohol addicted persons. Alcohol Alcohol 2008; 43: 347-50.
87. Matsui T., Yokoyama A., Matsushita S., Ogawa R., Mori S., Hayashi E. et al. Effect of a comprehensive lifestyle modification program on the bone density of male heavy drinkers. Alcohol Clin Exp Res 2010; 34: 869-75.
88. Nishiyori A., Shibata A., Ogimoto I., Uchimura N., Egami H., Nakamura J. et al. Alcohol drinking frequency is more directly associated with alcohol use disorder than alcohol metabolizing enzymes among male Japanese. Psychiatry Clin Neurosci 2005; 59: 38-44.
89. Nakamura Y., Ishikawa A., Sekiguchi S., Kuroda M., Imazeki H., Higuchi S. Spirits and gastrectomy increase risk for chronic pancreatitis in Japanese male alcoholics. Pancreas 2003; 26: e27-31.
90. Buster M., Rook L., van Brussel G. H., van Ree J., van den Brink W. Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 2002; 68: 221-8.
91. Lawal R. A., Adelekan M. L., Ohaeri J. U., Orija O. B. Rehabilitation of heroin and cocaine abusers managed in a Nigerian psychiatric hospital. East Afr Med J 1998; 75: 107-12.
92. Bogucka-Bonikowska A., Baran-Furga H., Chmielewska K., Habrat B., Scinska A., Kukwa A. et al. Taste function in methadone-maintained opioid-dependent men. Drug Alcohol Depend 2002; 68: 113-7.
93. Wapf V., Schaub M., Klaeusler B., Boesch L., Stohler R., Eich D. The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients. Harm Reduct J 2008; 18: 5-10.
94. Harris C. K., Warnakulasuriya K. A. A. S., Cooper D. J., Peters T. J., Gelbier S. Prevalence of oral mucosal lesions in alcohol misusers in south London. J Oral Pathol Med 2004; 33: 253-9.
95. Tacke U., Wolff K., Finch E., Strang J. The effect of tobacco smoking on subjective symptoms of inadequacy ('not holding') of methadone dose among opiate addicts in methadone maintenance treatment. Addict Biol 2001; 6: 137-45.
96. Best D., Lehmann P., Gossop M., Harris J., Noble A., Strang J. Eating too little, smoking and drinking too much: wider lifestyle problems among methadone maintenance patients. Addict Res Theory 1998; 6: 489-98.